Craig Reist is an accomplished inventor based in Charlottesville, VA (US). He has made significant contributions to the field of biomedical engineering, particularly in the area of immunology. With a total of 2 patents, his work focuses on innovative methods to enhance the efficacy of treatments involving red blood cells.

Latest Patents

One of Craig Reist's latest patents is titled "Mammalian primate erythrocyte bound heteropolymerized monoclonal." This invention utilizes mammalian red blood cells to safely and rapidly neutralize and clear antigens or immunogens from the circulatory system. The process involves binding a monoclonal antibody specific for a receptor (CR1) on the red blood cells. This monoclonal antibody is chemically bound to a second monoclonal antibody that targets the antigen to be cleared. These chemically cross-linked monoclonal antibody heteropolymers can be injected directly into the patient's circulatory system. Alternatively, red blood cells extracted from the patient or provided by a suitable donor can be bound to the monoclonal antibody complex and returned to the system.

Career Highlights

Craig Reist is affiliated with the University of Virginia Patent Foundation, where he continues to develop and refine his innovative ideas. His work has garnered attention for its potential to improve therapeutic outcomes in patients requiring rapid clearance of harmful substances from their blood.

Collaborations

Craig has collaborated with notable colleagues, including Ronald P. Taylor and William M. Sutherland. Their combined expertise has contributed to the advancement of research and development in their respective fields.

Conclusion

Craig Reist's innovative work in the field of immunology exemplifies the impact of scientific research on healthcare. His patents reflect a commitment to improving patient outcomes through advanced biomedical solutions.